Clinical Chemistry Total Allowable Error - Molecular Depot .

1y ago
25 Views
2 Downloads
1.22 MB
16 Pages
Last View : 20d ago
Last Download : 2m ago
Upload by : Maleah Dent
Transcription

Clinical Chemistry Total Allowable Error - Molecular Depot - hymotrypsinAATAATAATAlpha-1 antitrypsinAlpha 1 Angiotensin converting S-MethodLimit27.1%30 nmol/L, 15%Source5 BV7 RCPA20 umol/day, 20%7 RCPA16.8%5 BV /- 3 SD3 SD9.2%1 CLIA, 3 NYS, 6 AAB4 CAP5 BV3SD6 AAB17.9%5 BV25%2 WLSH /- 15%3 SD2.5 mg/mL or 25%3 NYS4 CAP6 AABAcetaminophen20%8 CFXAcetone25%2 WLSHS-BNIIS-P-Abbott AxSymACID PHOS Acid phosphataseS-10.3%5 BVACID PHOS Acid phosphatase tartrate resistentS-13.2%5 BVACID PHOS Acid Phos(Pros)1.5 U/L & ug/L, 15%7 RCPAACID PHOS Acid Phos(Total)1.5 U/L & ug/L, 15%7 RCPAACMVAnti-CMVPositive or Negative3 NYSACRATA/C Ratio2.5 SD2 WLSHACTACTActivated Clotting Time (ACT)Activated Clotting Time2 SD20%2 WLSH6 AABACTHACTH2.0 pmol/L, 10%7 RCPA16.7%5 BVADENOSINE Adenosine deaminaseS-ADRENAdrenaline50 nmol/day, 33%7 nAlpha fetoprotein (Prenatal screen)AFP (Amniotic Fluid)AFP (Maternal Sera)AFPTMAFPAFP, Amniotic FluidAFP-Tumor (Chiron)AFPAlpha-fetoprotein /- 3 SD3 SD /- 3 SD /- 3 SD /- 3 SD3 SD3 SD3 SD5 kIU/L, 20%5 kIU/L, 20%1233344477AHIVAnti-Human Immunodeficiency virusReaction or nonreactive1 CLIAALAUrine ALA5 umol/L, 25%7 RCPAALBAlbumin /- LBAlbuminAlbumin, concentration, first morningGlycated bloodEthanolALCOHOLALCOHOLEthanolEthanol, BloodAbbott AxSymHP GLCALCOHOLALCOHOLALCOHOLEthanol, UrineAlcohol, SerumAlcoholHP GLCALCOHOLEthanolALDALDAldosteroneAldosterone, IA, 2 WLSHWLSHNYSNYSNYSCAPCAPCAPRCPARCPAAU64010%1 CLIA, 2 WLSH, 3NYS, 6 AAB4 CAPBNIIBNII20%20%4 CAP4 CAP3.9%46.1%7.2%5 BV5 BV5 BV2.0 g/L, 10%0.10 g/L, 10%7 RCPA7 RCPA0.1 g/L, 10%10%7 RCPA8 CFXAlcohol, blood /- 25%Alcohol (Ethanol), UrinePos/Neg1 CLIA, 2 WLSH, 6AAB2 WLSH /- 10%20% or 2 SD3 NYS3 NYS80% consensus25%4 CAP4 CAP25% or 9 mg/dL (greater)25%2.2 mmol/L, 10%4 CAP6 AAB7 RCPA15%8 CFX36.7%39.6%5 BV5 BV75.0 pmol/L, 15%7 RCPAU-SU-

Clinical Chemistry Total Allowable Error - Molecular Depot - https://moleculardepot.comALKPAlkaline phosphataseALKPAlk PhosALKPALKPAlkaline phosphataseAlkaline phosphatase, bone isoformALKPALKPALKPAlkaline PhosphataseAlkaline PhosphataseAlkaline PhosphataseALTAlanine aminotransferase (ALT, SGPT)ALTALTALTALTAlanine aminotransferaseAlanine AminotransferaseALTALT /- 30%30%1 CLIA, 2 WLSH, 3NYS, 6 AAB4 CAP11.7%14.5%5 BV5 BV30%15 U/L, 15%30%6 AAB7 RCPA8 CFX /- 20%20%32.1%20%1 CLIA, 2 WLSH, 3NYS, 6 AAB4 CAP5 BV6 AABALTAlanine Aminotransferase8 U/L, 15%35%7 RCPA8 CFXAMIKACINAmikacin25%2 WLSHAMIKACINAMIKACINAmikacinAmikacin2.0 mg/L, 10%15%7 RCPA8 CFXAMIODAmiodarone0.2 umol/L, 10%7 RCPAAMITRIPAMITRIPAmitriptylineAmitriptyline10 umol/L, 10%15%7 RCPA8 CFXAMMAmmonia2.5 SD2 WLSHAMMAMMAMMAmmoniaAmmonia, outputAmmonia, Serumnot evaluated29.6%10 umol/L or 5%4 CAP5 BV6 AABAMMAmmonia3 umol/L, 10%7 esAmphetamines, qualitativeAmphetaminePos/Neg20% or 2 SDPresence or Absence80% consensus2334AMYAmylase /- 30%AMYAMYAMYAMYAMYAMYAMYAMYAmylase -urineAmylaseAmylase, urinea-Amylasea-Amylase (pancreatic)a-Amylase concentration, randomAmylaseAmylase1 CLIA, 2 WLSH, 3NYS, 6 AAB2 WLSH4 CAP4 CAP5 BV5 BV5 BV7 RCPA8 CFXANAAntinuclear S-AU640U-Abbott AxSymUUSSU-AU640AU64030%30%3 SD15.7%17.7%103.7%15 U/L, 15%20%WLSHNYSNYSCAPTarget value /- 2 dilution or (pos.or neg.)1 CLIA, 3 NYS22.6%2.0 nmol/L5 BV7 RCPATricyclic AntidepressantsPos/Neg2 WLSHTricyclic Antidepressants20% or 2 SD3 NYSTricyclic Antidepressants10 nmol/L, 10%7 RCPATricyclic Antidepressants15%8 CFX8.3%5 BV3 SD4 CAP9.1%25 mg/dL or 30%0.2 g/L, 10%5 BV6 AAB7 RCPA10%8 CFX3 SDnot evaluated4 CAP4 CAP11.6%20 mg/dL or 25%5 BV6 AAB0.2 g/L, 10%12%7 RCPA8 CFX /- 15%4.5%1 CLIA, 2 WLSH, 3NYS, 6 AAB5 BV15%6 AABTarget value /- 2 dilution or (pos.or neg.)2 SD1 CLIA, 3 NYS /- 20%20%1 CLIA, 2 WLSH, 3NYS, 6 AAB4 CAP15.2%20%8 U/L, 15%5 BV6 AAB7 RCPA20%8 CFXANTITHROM Antithrombin IIIAPOA1Apolipoprotein A1APOA1APOA1APOA1Apolipoprotein A1Apolipoprotein A1Apolipoprotein A1APOA1Apolipoprotein AIAPOBAPOBApolipoprotein bApolipoprotein B100APOBAPOBApolipoprotein BApolipoprotein BAPOBAPOBApolipoprotein BApolipoprotein BAPTTPartial thromboplastin timeAPTTActivated partial thromboplastine timeAPTTActivated Partial Thrombo TimeASOAntistreptolysin OASOAso-AntistreptolysinASTAspartate aminotransferase (AST, SGOT)ASTASTASTASTASTAspartate aminotransferaseAspartate AminotransferaseASTASTAspartate AminotransferaseS-P-BNIIS-BNIIBNIIS-P-BNIIAU640S-4 CAP

Clinical Chemistry Total Allowable Error - Molecular Depot - ituatesBARBBarbituratePos/Neg20% or 2 SD2 WLSH3 NYS80% consensus4 CAPBASOBasophile, count38.5%5 BVBCAROTBeta Carotene0.2 umol/L, 10%7 diazepinePos/Neg2 WLSH20% or 2 SD80% consensus3 NYS4 CAPBENZOYBenzoylecgonine20% or 2 SD3 NYSBILIBilirubin, total /- 0.4 mg/dL or /- 20% l0.4 mg/dL or 20%0.4 mg/dL or 20%1 CLIA, 2 WLSH, 3NYS, 6 AAB2 WLSH2 WLSHBILIBILIBILIBilirubin, Urine (qual)Bilirubin, DirectBilirubin, Total80% Agreement20% or 0.4 mg/dL (greater)20% or 0.4 mg/dL (greater)3 NYS4 CAP4 CAPBILIBILIBilirubin conjugatedBilirubin total44.5%31.1%5 BV5 BVBILIBILIBILIBilirubin, TotalDirect BilirubinBilirubin - Total0.4 mg/dL or 20%0.4 mg/dL or 20%5 umol/L, 10%6 AAB6 AAB7 RCPABILIBILIBilirubin ConjugatedConjugated Bilirubin, Neonatal10 umol/L, 20%10 umol/L, 20%7 RCPA7 RCPABILIBILIBILIBILITotal Bilirubin, NeonatalBilirubin - DirectBilirubin - NeonatalBilirubin - Total15 umol/L, 10%50%31%31%7888BNPBNPBNPBNPBNPBNP2.0 SDnot evaluated5.0 pg/mL or 20%2 WLSH4 CAP6 AABBPbBPb:C3C3C3Complement C3C3 ComplementC3 complementS-C4C4C4Complement C4C4 ComplementC4 complementS-CACACACACACACACalcium, IONCA-IONCA-IONCA-IONIonized CalciumCalcium, IonizedCalcium, ionizedIonized CalciumCA-IONCA-IONIonised CalciumCalcium - IonizedCA-URICA-URICalcium - urineCalcium, urineUU-CA-URICA-URICA-URICalcium, concentration, 24hCalcium, output, 24hCalcium-UrineUUU-CA125CA125CA125CA 125CA125CA 125 antigenS-CA125CA125CA-125CA125CA15CA 15-3CA15CA15CA15-3CA 15.3 antigenCA15CA15-3CA19CA19CA 19-9CA19-9CA19CA19CA 19.9 antigenCA19-9CA27CA27.29CA549CA 549 antigenAbbott AxSymS-Abbott AxSymAU640AU640SS-CentaurRCPACFXCFXCFX /-4 µg/dL (values 40µg/dL) or /- 3 NYS10% (values 40µg/dL)BNII /- 3 SD3 SD8.4%1 CLIA, 3 NYS, 6 AAB4 CAP5 BVBNII /- 3 SD3 SD16%1 CLIA, 3 NYS, 6 AAB4 CAP5 BV /- 1.0 mg/dL1 mg/dL2.4%1.0 mg/dL1.0 mg/dL0.10 mmol/L8%1456678CLIACAPBVAABAABRCPACFX0.13 mmol/L3 SD2.1%0.25 mmol/L2456WLSHCAPBVAAB0.05 mmol/L10%7 RCPA8 CFX1 mg/dL31%2 WLSH4 CAP34.1%31%0.20 mmol/L5 BV5 BV7 RCPA2 SD /- 3 SD38.2%2 WLSH3 NYS5 BV9 U/mL or 30%20 kU/L, 20%6 AAB7 RCPA2 SD2 WLSH /- 3 SD15.5%3 NYS5 BV3 kU/L, 15%7 RCPA2 SD /- 3 SD2 WLSH3 NYS44.3%3 kU/L, 15%5 BV7 RCPA /- 3 SD3 NYS16.2%5 BVAU640SU-Radiometer 725U-S-S-S-AU640

Clinical Chemistry Total Allowable Error - Molecular Depot - https://moleculardepot.comCAFFEINECaffeine15%8 CFXCALCITCalcitonin2 ng/L, 10%7 RCPACARBAMCarbamazepine /- 25%CARBAMCARBAMCarbamazepineCarbamazepine /- 15%25%1 CLIA, 2 WLSH, 6AAB3 NYS4 CAPCARBAMCARBAMCARBAMCarbamazepine, freeCarbamazepineCarbamazepine3 SD2.0 umol/L, 10%25%4 CAP7 RCPA8 moglobinFractional Carboxyhemoglobin3 SD3 SD0.022 WLSH4 CAP7 RCPACARCINOEMBCARCINOEMBCarcinoembryonic antigen21.8%5 BVCarcinoembryonic Antigen1.2 ng/mL or 30%6 AABCAROTTotal Carotenoids0.4 umol/L, 10%7 RCPAAbbott AxSymTDXRadiometer 725S-CAROTENE b-CaroteneS-43%5 BVCATECOLTotal catecolamines, concentration, 24hU-29.8%5 BVCD19CD19 3 SD2 WLSHCD2CD2 3 SD2 WLSHCD20CD20 3 SD2 WLSHCD3CD3CD3CD3CD3 CD3 /CD4 CD3 /CD8 CD3-/CD16 56 33332222CD4CD4 3 SD2 WLSHCD45Bright CD45-/CD14 3 SD2 WLSHCD5CD5 3 SD2 WLSHCD8CD8 3 SD2 WLSHCEACEACEACEACEACEACEACEA1.2 ng/mL or 30% /- 3 SD3 SD2.0 ug/L, 20%2347CELLIDCell identification90% or greater consensus onidentification1 CLIA, 3 NYSCERULOPCeruloplasmin3 SD4 CAPCERULOPCeruloplasminS-7.8%5 BVCHECHECholinesteraseCholinesterase, catalitic activitySS-8.9%7.4%5 BV5 BVCHOLCholesterol, total /- 10%CHOLCHOLCHOLCholesterolCholesterolCholesterol, Total10%9%10%1 CLIA, 2 WLSH, 3NYS, 6 AAB4 CAP5 BV6 AABCHOLCHOLCholesterolCholesterol - Total0.50 mmol/L, 5%9%7 RCPA8 CFXCHOL-HCholesterol, high dens. lipoprotein /- 30%CHOL-HCHOL-HCHOL-HHDL- CholesterolHDL 1 cholesterolHDL 2 cholesterolSS-30%11.5%23.9%1 CLIA, 2 WLSH, 3NYS, 6 AAB4 CAP5 BV5 BVCHOL-HCHOL-HHDL 3 cholesterolHDL cholesterolSS-9.8%11.1%5 BV5 BVCHOL-HCHOL-HHDL CholesterolHDL Cholesterol30%0.20 mmol/L, 10%6 AAB7 RCPACHOL-HCholesterol - HDL11%8 n-graded analyte2 WLSH3 NYSCHOL-LCHOL-LCHOL-LLDL- CholesterolLDL CholesterolLDL Cholesterol (Direct)20%13.6%15 mg/dL or 20%4 CAP5 BV6 AABCHOL-LCholesterol - LDL15%8 CFXAbbott SHWLSHNYSCAPRCPA

Clinical Chemistry Total Allowable Error - Molecular Depot - https://moleculardepot.comCIChlorideCIChloride -urine /- 5%5%1 CLIA, 2 WLSH, 3NYS, 6 AAB2 WLSHCICIChlorideChlorideAU640Radiometer 7255%5%4 CAP4 CAPCICICIChloride, urineChlorideChlorideUS-AU6403 SD1.5%3.0 mmol/L4 CAP5 BV7 ide2 mmol/L, 10%2.0 mmol/L, 10%7 RCPA7 RCPA5%8 CFXCKCreatine kinaseCKCKCK, TotalCreatine kinase /- 30%30%30.3%1 CLIA, 2 WLSH, 3NYS, 6 AAB4 CAP5 BVCKCKCKCreatine KinaseCreatine KinaseCreatine Kinase30%15 U/L, 15%30%6 AAB7 RCPA8 CFXCKMBCreatine kinase isoenzymesMB elevated (present or absent) or 1 CLIA, 2 WLSH, 3Target value /- 3 SD CreatinineNYS, 6 AABCKMBCKMBCK-MB qualitativeCk-MBPos/Neg3 SD2 WLSH4 CAPCKMBCKMBCreatine kinase MB, %Creatine kinase MB, activitySS-16.5%24.1%5 BV5 BVCKMBCKMBCKMBCreatine kinase MB, massCK2 Isoenzyme (CKMB)CK-MBS-31.2%3SD6 U/L & ug/L, 15%5 BV6 AAB7 RCPACKMBCKMBCK-MB ActivityCK-MB Mass40%2 SD8 CFX8 CFXCO2Carbon Dioxide5.0 mmol/L2 WLSHCO2CO2CO2CO2CO2Bicarbonate (Total CO2)BicarbonateCO2 - Total3 SD4 mEq/L or 20%2.0 mmol/L, 10%20%4678COCAINECOCAINECocaine MetabCocaine-MetabolitePos/Neg80% consensus2 WLSH4 CAPCONDUCSweat Conductivity2 mmol/L, 10%7 RCPACOPPERCOPPERCopperCopper11.8%7.7%5 BV5 BVCORTCortisol /- l25%29.8%30 nmol/L, 15%30%1 CLIA, 2 WLSH, 3NYS, 6 AAB4 CAP5 BV7 RCPA8 CFXCPEPCPEPCPEPC PeptideC-Propeptide type I procollagenC Peptide11.7%11.6%1.0 nmol/L, 10%5 BV5 BV7 RCPACREACreatinine /- 0.3 mg/dL or /- 15% (greater)CREACREACREACREACREACREACreatinine - quantitative, UrineCreatinine - semi quant, UrineCreatinineCreatinine, urineCreatinineCreatinine clearence0.3 mg/dL or 17%USPatient-15% or 0.3 mg/dL (greater)17%6.9%16%1 CLIA, 2 WLSH, 3NYS, 6 AAB2 WLSH2 WLSH4 CAP4 CAP5 BV5 BVCREACreatinine, concentrationU-28.4%5 BVCREACREACREACreatinine, outputDeoxipyridinoline/creatinine, morning spUrine CreatinineUUU-15.4%33%3 mg/dL or 15%5 BV5 BV6 AABCREACREACreatinineCreatinine-UrineU-0.01 mmol/L, 10%0.5 mmol/L, 10%7 RCPA7 RCPACREACreatinine25%8 CFXCRPCRPhS-CRPCRP2.0 SD2 SD2 WLSH4 CAPCRPCRPCRPhs-CRPC-Reactive proteinCRPnot evaluated68.3%0.4 mg/dL or 3 SD%4 CAP5 BV6 AABCRPhigh sensitivity CRP0.4 mg/L or 3 SD%6 AABPositive or Negative or /- 2dilutions3 NYS3 SD4 CAP8.3%5 BVU-AU640S-CentaurAU640Abbott AxSymPS-CentaurS-SS-AU640AU640BNIIBNIIS-CRYPTOCO Cryptococcus neoformans mer (interpretation)Pos/Neg2 WLSHDDIMDDIMd-Dimer (quantitative)d-Dimer (semi-quantitative)2 SDPos/Neg2 WLSH2 WLSHDDIMD-Dimer30%6 AAB22.2%5 BVDEHYDROE Dehydroepiandrosterone sulfateTDXCAPAABRCPACFXP-S-

Clinical Chemistry Total Allowable Error - Molecular Depot - creatinine, 24hDESIPU-21.2%5 BVDesipramine15%8 CFXDHEADHEA Sulfate2.5 SD2 WLSHDHEADHEADHEA SulphateDHEA Sulphate1.0 umol/L, 10%2 SD7 RCPA8 CFXDIFFAutomated Differential3SD6 AABDIGDigoxin /- 20% or 0.2 ng/mL (greater)DIGDIGDigoxinDigoxin15% or 0.2 ng/mL20% or 0.2 ng/mL (greater)1 CLIA, 2 WLSH, 6AAB3 NYS4 CAPDIGDIGDigoxinDigoxin0.2 nmol/L, 10%25%7 RCPA8 CFXDIPEPDipeptidyl-peptidase IV10.9%5 BVDISOPDisopyramide2.0 umol/L, 10%7 RCPADISOPDisopyramide15%8 CFXDMFDMF0.45 mmol/L or 30%6 AABDOPDopamine0.25 umol/day, 25%7 RCPADPDDPDDPD (Free)-UrineDPD (Total)-Urine15 nmol/L, 15%15 nmol/L, 15%7 RCPA7 RCPADRYWTFaecal Percent Dry Weight1, 10%7 RCPAELASTASEElastase-PlP-16.5%5 BVEOSEosinophils, countB-37.1%5 BVEPEP:ERYTHErythrocyte countERYTHERYTHErythrocites, countErythrocytesESRESRESRSedimentation Rate [ESR]Erythrocyte Sedimentation Rate (ESR)Erythrocyte Sedimentation Rate (ESR) RapidCentaurP-UU- /-6 µg/dL (values 40µg/dL) or /- 3 NYS15% (values 40µg/dL)4.4%6%1 CLIA, 2 WLSH, 3NYS, 6 AAB5 BV6 AAB2.5 SD3SD3SD2 WLSH6 AAB6 AABESTRADIOL Estradiol3 ng/mL or 30%2 WLSHESTRADIOL Estradiol /-25% or 30 pg/mL3 NYS27%5 BVESTRADIOL Estradiol3 pg/mL or 30%6 AABESTRADIOL Oestradiol100 pmol/L, 20%7 RCPAESTRADIOL Estradiol2 SD8 CFXESTRIOLEstriol2.5 SD2 WLSHESTRIOLESTRIOLFree EstriolTotal Estriol /-25% or 3.0 ng/mL /-25% or 3.0 ng/mL3 NYS3 conjugated)Estriol - Total20 nmol/L, 10%5 nmol/L, 20%2 SD7 RCPA7 RCPA8 CFXESTRIOLEstriol - Unconjugated2 SD8 CFXESTROGEN Estrogen2.5 SD2 WLSHETHOSUXEthosuximide /- 20%1 CLIA, 2 WLSHETHOSUXETHOSUXEthosuximideEthosuximide /- 15%3 umol/L, 10%3 NYS7 RCPAETHOSUXEthosuximide15%8 CFXFACTORFACTORFactor VII coagulationFactor VIII coagulationPP-10.7%8.9%5 BV5 BVFACTORTumor Necrosis Factor-aS-48.4%5 BVFBGFibrinogen /- 20%FBGFibrinogen13.6%1 CLIA, 2 WLSH, 3NYS, 6 AAB5 BVFENTFentanyl20% or 2 SD3 NYSESTRADIOL Estradiol /- 6%B-U-P-

Clinical Chemistry Total Allowable Error - Molecular Depot - FerritinFerritinFerritine4.5 ng/mL or 30%3 SD17.3%2 WLSH4 CAP5 BVFERRITINFERRITINFerritinFerritin4.5 ng/mL or 30%6.0 ug/L, 15%6 AAB7 RCPAFERRITINFerritin19.3%8 CFXFK506Tacrolimus (FK 506)3 SD4 CAPFOLATEFOLATEFolateRBC Folate0.9 ng/mL or 30%2.5 SD2 WLSH2 WLSHFOLATEFOLATEFolate, SerumFolate3 SD26.7%4 CAP5 BVFOLATEFOLATEFOLATEFolateFolateFolate39%0.9 ng/mL or 30%1.0 umol/day, 30%5 BV6 AAB7 RCPAFOLATEFolate2 SD8 CFXFOLICFolic Acid /- 30% or 2.0 ng/mL3 NYSFRUCTFructosamine4.5%5 BVFRUCTFructosamine30 umol/L, 10%7 RCPAFSHFSHFSHFSH2 mIU/mL or 25% /-25%2 WLSH3 NYSFSHFSHFSHFSHFollicle stimulating hormoneFollicle-Stimulating Hormone3 SD16.7%2 mIU/mL or 25%4 CAP5 BV6 AABFSHFSHFSHFollicle Stimulating Hormone4.0 IU/L, 20%2 SD7 RCPA8 CFXFT3FT3FT3FT3Free T3Triiodothyronine, Free (Free T3)Free T3Triiodothyronine - Free3 SD1.5 pg/mL or 30%3.0 pmol/L20%2678FT4Free thyroxine /- 3 SDFT4FT4FT4FT4FT4FT4T4, FreeFree thyroxine (FT4)Thyroxine, FreeFree T4 (Endocrinology)Free T4 (General Chemistry)Thyroxine - Free3 SD9.9%3SD1.5 pmol/L, 15%3 pmol/L, 15%2 SD1 CLIA, 2 WLSH, 3NYS4 CAP5 BV6 AAB7 RCPA7 RCPA8 CFXGASTRINGastrin25 pmol/L, 10%7 RCPAGENTAGentamicin /- cinGentamicin /- 15%25%0.5 mg/L, 10%20%1 CLIA, 2 WLSH, 6AAB3 NYS4 CAP7 RCPA8 CFXGGTGGTGGTGGTGGTGGTGGTGamma-glutamyl transferase [GGT]Gamma lutamyl-transferaseGGTGamma-Glutamyltransferase20% /- 30%3 SD22.2%10 IU/L or 20%8 U/L, 15%30%2345678GHGrowth Hormone2 mU/L, 20%7 RCPAGLOBGLOBa1-Globulinsa2-GlobulinsSS-15.7%12.6%5 BV5 nsSSS-11.7%9%16.8%5 BV5 BV5 BVGLOBGLOBGlobulins, totalBeta 2 microglobulinS-8%0.06 mg/L or 30%5 BV6 AABGLOBBeta-2 Microglobulin0.2 mg/L, 10%7 RCPAGLUGlucose /- 6 mg/dL or /- 10% (greater)GLUGlucose -urine10%1 CLIA, 2 WLSH, 3NYS, 6 AAB2 WLSHGLUGLUGlucose, CSFGlucose, Whole Blood10%20 mg/dL or 20%2 WLSH2 WLSHGLUGLUGLUGlucose, Urine (qual)GlucoseGlucose80% Agreement10% or 6 mg/dL (greater)10% or 6 mg/dL (greater)3 NYS4 CAP4 CAPGLUGLUGlucose, UrineGlucose10% or 6 g/24 hs (greater)6.3%4 CAP5 e Blood GlucoseGlucose(B)Erythr-38.5%6 mg/dL or 10%0.5 mmol/L, 10%5 BV6 AAB7 RCPAGLUGLUGlucose-Blood GasGlucose-CSFBGCSF1.0 mmol/day, 10%1.0 mmol/L, 10%7 RCPA7 RCPAGLUGLUGlucose-UrineGlucose (GLUC )U-1.0 mmol/L, 10%0.3 mmol/L, 8.0%7 RCPA8 CFXS-16.2%5 BVGLYCOPRO a1-Acid rS-CentaurS-Abbott AxSymAU640S-U-AU640Radiometer 725AU640S-WLSHAABRCPACFXWLSHNYSCAPBVAABRCPACFX

Clinical Chemistry Total Allowable Error - Molecular Depot - https://moleculardepot.comH2OWaterS-3.3%5 BVHAPTHAPTHaptoglobinHaptoglobinP, S-not evaluated27.3%4 CAP5 BVHBA1CHBA1CHBA1CHemoglobin A1c1.0 or 25%2 WLSHHemoglobin,Total A1Total Glycated Hemoglobin1.0 or 25%1.2 or 20%HBA1CHBA1CHBA1CHemoglobin A1 CGlycohemoglobinHemoglobin A1C2 WLSH2 WLSH4.4%1.00% or 25%0.5, 5%5 BV6 AAB7 RCPAHBA1CGlycated Hemoglobin A1c9%8 CFXHCGHuman chorionic gonadotropin /- 3 SD or (positive or negative)HCGhCG,qualitative (serum)Pos/Neg1 CLIA, 2 WLSH, 3NYS, 6 AAB2 WLSHHCGHCGHCGhCG (Maternal Sera)Qualitative hCGTotal Beta hCG /- 3 SDPositive or Negative /- 3 SD3 NYS3 NYS3 NYSHCGHCGhCG, QuantHuman Chorionic Gonadotropin3 SD3SD4 CAP6 hCG3.0 IU/L, 15%5 IU/L, 10%32%7 RCPA7 RCPA8 CFXHCTHematocrit /- 6%HCTHematocrit1 CLIA, 2 WLSH, 3NYS, 6 AAB5 BVHEPATHepatitis (HBsAg, anti-HBc, HBeAg)HEPATHepatitis (Anti-HBc HBsAg HBeAg Anti-HCV)BNIIS-CentaurU-B-4.1%Reactive (positive) or nonreactive(negative)Reactive (Positive) or Nonreactive(Negative)1 CLIAHETEROPHI HeterophileLEPositive or Negative or /- 2dilutions3 NYSHGBHemoglobin /- 7%HGBHGBHGBHGBHemoglobin,totalHemoglobin, Urine (qual)HemoglobinHemoglobin concentration7%80% Agreement4.1%3 g/L, 3%1 CLIA, 2 WLSH, 3NYS, 6 AAB2 WLSH3 NYS5 BV7 RCPAHIDROX5'-Hidroxiindolacetate, concentration, 226.5%5 BVHMMAHMMA20 umol/day, 20%7 aded analyte3 SD17.7%2.5 umol/L or 20%15%34568HVAHVA8 umol/day, 25%7 ydroxyprogesteroneGalactosy ne/minute, night a-Hydroxybutyric Acid30.2%16.8%32.9%43%3 nmol/L, 20%10 umol/L, 10%2 SD5555778IGAIGAIGAIgAIgA, BloodImmunoglobulin A /- 3 SD3 SD13.5%1 CLIA, 3 NYS, 6 AAB4 CAP5 BVIGBIgB /- 3 SD1 CLIAIGEIGEIgEIgE /- 3 SD3SD3 NYS6 AABIGEIGEIgEIgE3SD4.0 IU/L, 20%6 AAB7 RCPAIGFIGF-13 nmol/L, 15%7 RCPAIGGIgG /- 25%1 CLIA, 3 NYS, 6 AABIGGIGGIgG, BloodIgG-BloodBNIIBNII25%3 SD4 CAP4 CAPIGGIGGIGGIgG-CSFImmunoglobulin GImmunoglobin G-CSFBNIISCSF3 SD8%0.1 g/L, 10%4 CAP5 BV7 RCPAIGIImmunoglobulins l chainS-8.6%5 BVIGKImmunoglobulins K chainS-8%5 BVIGMIgM /- 3 SD1 CLIA, 3 NYS, 6 AABB-U-IMXP-SSSUU-BNIIS-Opt3 NYSNYSCAPBVAABCFXBVBVBVBVRCPARCPACFX

Clinical Chemistry Total Allowable Error - Molecular Depot - https://moleculardepot.comIGMIgM, BloodIGMImmunoglobulin MIMIPImipramineIMMUNOFImmunofix UrineIMMUNOFImmunofixation linBNIIS-Sebia HydrasisLSSebia HydrasisLS3 SD4 CAP16.8%5 BV15%8 CFX90% consensus4 CAP90% consensus4 CAP2 SD2 WLSH /-25% or 3.0 uU/mL3 NYSS-32.9%5 mU/L, 25%5 BV7 RCPAINTERFERO Interferon receptorN(B)Leuc-17.7%5 BVINTERLEUKI Interleukin-1BNINTERLEUKI Interleukin-8NS-36.5%5 BVS-29.6%5 BV /- 20%20%3 SD30.7%1 CLIA, 2 WLSH, 3NYS, 6 AAB4 CAP4 CAP5 BV20%5 umol/L31%6 AAB7 RCPA8 CFXnot evaluated4 CAP80% Agreement3 NYS0.2 mmol/L or 2SD2 SD30.4%1.0 mmol/L, 10%1.0 mmol/day, 10%0.1 mmol/L, 10%30%2445777816.4%0.5 mg/mL or 20%5 BV6 AAB /- 20%1 CLIA, 2 WLSH, 3NYS, 6 AAB4 CAP5 BV6 AAB7 RCPA8 CFXIRONIron, totalIRONIRONIRONIronIron opanolKETONESKetones, Urine ferrinLDHLactate dehydrogenase ctateLDH1LDH isoenzymesLDH1Lactate dehydrogenase 1 isoform (LDH1)S-LDH1/LDH2 ( or -) or Target value 1 CLIA, 3 NYS /- 30%8.2%5 BVLDH2Lactate dehydrogenase 2 isoform (LDH2)S-5.7%5 BVLDH3LDH3Lactate dehydrogenase 3 isoform (LDH3)LD Isoenzymes 3-5S-5.8%3.00% or 30%5 BV6 AABLDH4Lactate dehydrogenase 4 isoform (LDH4)S-11%5 BVLDH5Lactate dehydrogenase 5 isoform (LDH5)S-14.8%5 BVLEADLEADBlood leadLead, Blood /- 10% or /- 4 mcg/dL (greater)10% or 4 ug/dL (greater)1 CLIA, 2 WLSH4 CAPLHLH2.5 SD2 WLSHLHLHLHLH /-25% or 1.5 IU/L3 SD3 NYS4 CAPLHLHLHLuteinizing hormoneLuteinizing HormoneLH19.8%2 mIU/mL or 25%2.0 IU/L, 20%5 BV6 AAB7 RCPALHLuteinizing Hormone2 SD8 CFXLIGNOLignocaine2.0 umol/L, 10%7 RCPALIPASELipase30%2 %4 CAP5 BV6 AABLIPASELIPASELipaseLipase40 U/L, 20%37%7 RCPA8 CFXDehydrogenasedehydrogenase alculated(B)Leuc-HP GLCAU640Radiometer 725B-CSFPOptAU640S-Spectra AACentaurS-AU640S-20%11.4%20%30 U/L, 15%20%WLSHCAPCAPBVRCPARCPARCPACFX

Clinical Chemistry Total Allowable Error - Molecular Depot - https://moleculardepot.comLIPOPLIPOPLipoprotein (a)Lipoprotein (a)28.8%10 mg/dL or 30%5 BV6 AABLIPOPLipoprotein (a)S-2 SD8 CFXLITHIUMLithium /- 20% or 0.3 mmol/LLITHIUMLithium /- 15% or 0.3 mmol/L1 CLIA, 2 WLSH, 6AAB3 NYSLITHIUMLITHIUMLITHIUMLithiumLithiumLithium20% or 0.3 mEq/L (greater)0.2 mmol/L10%4 CAP7 RCPA8 CFXLYLymphocytes, countB-16%5 BVMCHMean corpuscular hemoglobin (HCM)(B)Erythr-2.7%5 BVMCHCMean corpuscular hemoglobin concentratio(B)Erythr-2.2%5 BVMCVMCVMCVMean corpuscular volume (MCV)(B)Erythr-3 SD2.3%2 WLSH5 BVMETANMetanephrine0.5 umol/day, 33%7 RCPAMETHADON MethadonePos/Neg2 WLSHMETHADON Methadone20% or 2 SD3 NYSAVL 9180METHANOL MethanolHP GLCnot evaluated4 ctional MethemoglobinRadiometer 7253 SD2%1.0, 10%2 WLSH4 CAP7 RCPAMETHOTMETHOTMethotrexateMethotrexate0.1 umol/L, 10%25%7 RCPA8 CFXMETHQMethqualonePos/Neg2 WLSHMGMagnesium /- 25%MGMGMGMGMGMGMGMGMGMGMGMGMGMagnesium - urineMagnesiumMagnesium, urineMagnesiumMagnesiumMagnesiumMagnesium, concentration, 24hMagnesium, ionizedMagnesium, output, 24hMagnesiumMagnesium (serum)MagnesiumMagnesium - Ionized25%25%25%7.8%21.2%4.8%52.2%2.9%45%3 mmol/L0.12 mmol/L0.1 mmol/L, 12%10%1 CLIA, 2 WLSH, 3NYS, 6 AAB2 WLSH4 CAP4 CAP5 BV5 BV5 BV5 BV5 BV5 BV7 RCPA7 RCPA8 CFX8 CFXMICROALBMICROALBMICROALBMicroalbumin - quantitativeMicroalbumin, urineUrine MicroalbuminUU-2.5 SD3 SD10 mg/L or 25%2 WLSH4 CAP6 AABMICROGLOBMICROGLOBMICROGLOBa1-Microglobulin, concentration, first mU-43.9%5 BVa2-MacroglobulinS-7.6%5 BVa2-Microglobulin output, overnightU-34.7%5 BVMONOMonocytes, countB-27.9%5 BVMONONUCInfectious mononucleosisTarget value /- 2 dilution or (pos.or neg.)1 CLIAMPVMean platelet volume (MPV)(B)Plat-5.8%5 BVMRNALDL receptor mRNAS-24.1%5 BVMSAFPMSAFPCentaur3 SD4 CAPMSHCGMShCGCentaur3 SD4 CAPMUCINMucinous carcinoma-associated antigen (M S-18.5%5 BVMYOGLOBMYOGLOBMyoglobin - qualitativeMyoglobin - quantitativePos/Neg2 SD2 WLSH2 WLSHMYOGLOBMYOGLOBMyoglobinMyoglobin19.6%15 ng/mL or 30%5 BV6 AABUU(B)Erythr(B)LeucSUUU-AU640AU640U-S-AU640

Clinical Chemistry Total Allowable Error - Molecular Depot - https://moleculardepot.comMYOGLOBMyoglobin30%8 CFXNACETN-Acetyl Glucosaminidase, concentration,NACETN-Acetyl Glucosaminidase, outputU-53.1%5 BVU-46.5%5 BVNEUNeutrophyles, countB-22.4%5 BVNITROGENNitrogen, outputU-18.4%5 BVNORADNoradrenaline50 nmol/day, 10%7 RCPANORMETNormetanephrine1.0 umol/day, 33%7 RCPANORTRIPNORTRIPNortriptylineNortriptyline10 nmol/L, 10%15%7 RCPA8 CFXNSENSE2.0 ug/L, 10%7 RCPANUCLEO5'Nucleotidase26.8%5 BVOLIGOCLOligoclonal Bands90% consensus4 CAPOPIATESOPIATESOpiatesOpiatesPos/Neg20% or 2 SD2 WLSH3 NYSOPIATESOpiate80% consensus4 , eOsmolality3 SD3 SD2 SD3 SD1.5%9. mOsm/kg or 10%8 mmol/kg6 mmol/kg, 2%3%224456778OSTOsteocalcinS-11.2%5 BVOXALATEOXALATEOxalate, concentrationOxalate, outputUU-48.2%46.8%5 BV5 tional Oxyhemoglobin3 SD3, 4%2 WLSH4 CAP7 RCPAPAPPAP2.5 SD2 WLSHPARACETParacetamol20 umol/L, 10%7 RCPAPCO2Blood gas pCO2 /- 5 mm Hg or /- 8% (greater)PCO2PCO2PCO2PCO2pCO2pCO2pCO2pCO28% or 5 mm Hg (greater)5.7%5.0 mm Hg or 8%2.0 mm Hg, 8%1 CLIA, 2 WLSH, 3NYS, 6 AAB4 CAP5 BV6 AAB7 RCPAPCO2pCO25 kPa, 8%8 CFXPEROXGlutathione peroxidase11.7%5 BVPHBlood gas pH /- 0.04PHpH, Urine (qual)80% Agreement1 CLIA, 2 WLSH, 3NYS, 6 AAB3 NYSPHPHpHpH,Fluid0.040.044 CAP4 CAPPHpH [H ]3.9%5 BVPHPHPHpHpHpH0.040.040.046 AAB7 RCPA8 ncyclidinePos/Neg20% or 2 SD80% consensus2 WLSH3 NYS4 enobarbital /- 20%Phenobarbital /- 15%1 CLIA, 2 WLSH, 6AAB3 NYSPhenobarbitalS-Sebia HydrasisLSAbbott AxSymUUSU-Freezing pointFreezing pointU-Radiometer 725Radiometer 725B-S-Radiometer 725Corning 445 pHmeterB-Abbott AxSym20%4 CAPPhenobarbitone3.0 umol/L, 10%7 RCPAPhenobarbital20%8 CFX /- 25%1 CLIA, 2 WLSH, 6AABPHENYTOIN PhenytoinAbbott AxSymWLSHWLSHCAPCAPBVAABRCPARCPACFX

Clinical Chemistry Total Allowable Error - Molecular Depot - https://moleculardepot.comPHENYTOIN Free phenytoin /- 20%3 NYSPHENYTOIN Phenytoin /- 15%3 NYSPHENYTOIN PhenytoinAbbott AxSym25%4 CAPPHENYTOIN Phenytoin, freeTDX3 SD4 CAPPHENYTOIN Phenytoin3.0 umol/L, 10%7 RCPAPHENYTOIN Phenytoin25%8 CFXPHOSLHOL PhospholipidsS-8.6%5 BVPHOSPATE Phosphate-UrineU-2.5 mmol/L7 hosphateS-10.2%5 BVPhosphate tubular reabsorptionPatient-3.3%5 BVPhosphate, concentrationU-31.1%5 BVPhosphate, outputU-22.1%5 BV0.1 mmol/L, 10%7 ORUSPHOSPHORUSPHOSPHORUSPHOSPHORUSPhosphorus0.5 mg/dL or 12%2 WLSH0.5 mg/dL or 12%2 WLSH /- 0.45 mg/dL or 13%3 NYSAU64010.7% or 0.3 mg/dL (greater)4 CAPAU64023%4 CAP0.4 mg/dL or 15%6 AAB3. mg/dL or 15%6 AAB12%8 CFXPLTPlatelet count /- 25%PLTPLTPlatelet, countPlatelets1 CLIA, 2 WLSH, 3NYS, 6 AAB5 BV6 AABPO2Blood gas tePhosphorus -urineU-PhosphorusPhosphorusPhosphorus, urineU-PhosphorusPhosphorusU-PhosphorusB-13.4%25% /- 3 SD3 SD3SD5 mm Hg, 5%2 SD1 CLIA, 2 WLSH, 3NYS, 6 AAB4 CAP6 AAB7 RCPA8 CFXPolylysine45 mmol/L or 30%6 AABFaecal Total PorphyrinUrine Porphobilinogen (Quantitative)15 umol/kg, 15%5 umol/L, 20%7 RCPA7 RCPAPORPHYRIN Plasma Total Porphyrin3 nmol/L, 15%7 RCPAPORPHYRIN RBC Total Porphyrin0.3 umol/L rc, 15%7 RCPAPORPHYRIN Urine Total Porphyrin15 nmol/L, 15%7 RCPA /- 0.5 mmol/L2 SD0.5 mmol/L29%0.5 mmol/L1 CLIA, 2 WLSH, 3NYS, 6 AAB2 WLSH4 CAP4 CAP4 CAPRadiometer 725POTPotassiumPOTPOTPOTPOTPotassium - urinePotassiumPotassium, urinePotassium U-POTPOTPotassiumPotassium(B)LeucS-16%5.8%5 BV5 BVPOTPOTPOTPotassium, concentrationPotassium, outputPotassiumUU-31.3%28.4%0.2 mmol/L5 BV5 BV7 RCPAPOTPOTPotassium-POCTPotassium-UrinePOCTU-2.0 mmol/L2.0 mmol/L, 10%7 RCPA7 RCPAPOTPotassium6%8 CFXPREALBPREALBPre-albuminPrealbumin2.5 SD25% or 5 mg/dL (greater)2 WLSH4 CAPPREALBPrealbumin14.5%5 BVPREGPregnancy, Serumpos/neg6 AABPRIMIDONE Primidone /- 25%PRIMIDONE Primidone /- 15%1 CLIA, 2 WLSH, 6AAB3 NYSPRIMIDONE Primidone15%8 CFXPROCProcainamide (and metabolite) /- 25%PROCN-acetyl procainamide /- 15%1 CLIA, 2 WLSH, 6AAB3 NYSU-Radiometer 725AU640AU640BNIIS-

Clinical Chemistry Total Allowable Error - Molecular Depot - PROCN-acetylprocainamideNapaProcainamide /- 15%3 NYS25%25%25%4 CAP4 CAP4 CAPPROCPROCProcainamideProcainamide, N-Acetyl (NAPA)25%25%6 AAB6 AABPROCPROCN-acetylprocainamideProcainamide20%20%8 CFX8 CFXPROCOLLC-Telopeptide type I procollagenS-14.1%5 BVPROCOLLProcollagen type 1 N-terminalS-10.5%5 BVPROGESTPROGESTProgesteroneProgesterone300 pg/mL or 30% /-25% or 1.0 ng/mL2 WLSH3 ogesterone3 SD0.3 ng/mL or 30%2 nmol/L, 25%4 CAP6 AAB7 RCPAPROGESTProgesterone2 SD8 CFXPROLACTIN Prolactin3.6 ng/mL or 30%2 WLSHPROLACTIN Prolactin /-25% or 1.0 ug/L3 NYS3 SD4 CAP21.1%5 BVPROLACTIN Prolactin3.6 ng/mL or 30%6 AABPROLACTIN Prolactin20 mU/L, 20%7 RCPAPROLACTIN Prolactin2 SD8 CFX19.3%5 BVAbbott AxSymAbbott AxSymAbbott AxSymCentaurPROLACTIN ProlactinPROLACTIN Prolactin (men)CentaurS-PROLYLProlyl ePos/Neg20% or 2 SD2 WLSH3 NYSPROTEINTotal protein /- in,total - urineProtein, Urine (qual)CSF ProteinM-Protein Interpr.10%10%80% Agreement2 SD90% consensus1 CLIA, 2 WLSH, 3NYS, 6 AAB2 WLSH2 WLSH3 NYS4 CAP4 CAPPROTEINProtein El. Interpr, Serum90% consensus4 CAPPROTEINProtein El. Interpr, Ur 2490% consensus4 CAPPROTEINProtein El. Interpr, Urine90% consensus4 NProtein, TotalTotal protein, urineGlycated total proteinProtein CProtein SProtein, concentrationProtein, outputProtein, totalTotal ProteinTotal ProteinProtein (Total)Total Protein-CSFTotal Protein-UrineProtein - Total10%44%3.7%18.7%20.7%43.5%40%3.4%10%1.0 mg/dL or 25%5.0 g/L0.1 g/L, 10%0.1 g/L, 10%6%44555555667778PSAPSAPSAPSAPSA - freecPSA0.9 ng/mL or 30%0.9 ng/mL or 30% /- 3 SD2 WLSH2 WLSH3 NYSPSAfPSA /- 3 SD3 NYSPSAPSAPSAPSAPSAPSAProstatic specific antigen (PSA)Prostate-Specific Antigen /- 3 SD3 SD30%0.9 ng/mL or 30%3456PSAPSAFree PSATotal PSA1.5 ug/L, 15%1.5 ug/L, 15%7 RCPA7 RCPAPTProthrombin time /- 15%PTPTProthrombin timeCoaguChek Prothrombin Time5.3%15%1 CLIA, 2 WLSH, 3NYS, 6 AAB5 B

AHIV Anti-Human Immunodeficiency virus Reaction or nonreactive 1 CLIA ALA Urine ALA 5 umol/L, 25% 7 RCPA ALB Albumin /- 10% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB ALB Albumin AU640 10% 4 CAP ALB Albumin-Blood BNII 20% 4 CA

Related Documents:

Min Longitude Error: -67.0877 meters Min Altitude Error: -108.8807 meters Mean Latitude Error: -0.0172 meters Mean Longitude Error: 0.0028 meters Mean Altitude Error: 0.0066 meters StdDevLatitude Error: 12.8611 meters StdDevLongitude Error: 10.2665 meters StdDevAltitude Error: 13.6646 meters Max Latitude Error: 11.7612 metersAuthor: Rafael Apaza, Michael Marsden

Chemistry ORU CH 210 Organic Chemistry I CHE 211 1,3 Chemistry OSU-OKC CH 210 Organic Chemistry I CHEM 2055 1,3,5 Chemistry OU CH 210 Organic Chemistry I CHEM 3064 1 Chemistry RCC CH 210 Organic Chemistry I CHEM 2115 1,3,5 Chemistry RSC CH 210 Organic Chemistry I CHEM 2103 1,3 Chemistry RSC CH 210 Organic Chemistry I CHEM 2112 1,3

We can overcome these medication errors by educating physicians, nurses regarding the areas where medication errors are more prone to occur. Key words: Medication error, Prescribing error, Dispensing error, Administration error, Documentation error, Transcribing error, EPA (Electronic prior authorization), Near miss, Missed dose. INTRODUCTION

Physical chemistry: Equilibria Physical chemistry: Reaction kinetics Inorganic chemistry: The Periodic Table: chemical periodicity Inorganic chemistry: Group 2 Inorganic chemistry: Group 17 Inorganic chemistry: An introduction to the chemistry of transition elements Inorganic chemistry: Nitrogen and sulfur Organic chemistry: Introductory topics

Accelerated Chemistry I and Accelerated Chemistry Lab I and Accelerated Chemistry II and Accelerated Chemistry Lab II (preferred sequence) CHEM 102 & CHEM 103 & CHEM 104 & CHEM 105 General Chemistry I and General Chemistry Lab I and General Chemistry II and General Chemistry Lab II (with advisor approval) Organic chemistry, select from: 9-10

CHEM 0350 Organic Chemistry 1 CHEM 0360 Organic Chemistry 1 CHEM 0500 Inorganic Chemistry 1 CHEM 1140 Physical Chemistry: Quantum Chemistry 1 1 . Chemistry at Brown equivalent or greater in scope and scale to work the studen

APPLICATION FOR ALLOWABLE EXPENDITURE CREDIT TEMPLATE BMS-FM-015, Rev. 1 Legal Services Page 2 of 10 / 2 Instructions 1) The Allowable Expenditure Credit Guideline (AEC Guideline) should be consulted in conjunction with completing the Application for Allowable Expenditure

(a)What is the Allowable deflection in inches, if the allowable deflection DL LL due to is L/240; If the load applied represent the Dead and Live loads, determine if the beam deflection is acceptable? Solution: Refer to table 1(pg2) for allowable L/240 1 inch since the Actual deflection (0.406in) is Less than the Allowable